Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Neuberg Centre For Genomic Medicine, |
RCV001823483 | SCV002072951 | uncertain significance | Generalized epilepsy with febrile seizures plus, type 2 | criteria provided, single submitter | clinical testing | The missense variant p.M251V in SCN1A (NM_001165963.4) has not been reported previously as a pathogenic nor a benign variant to the best of our knowledge. Another missense mutation affecting the same residue M251R has been previously reported to be disease causing. The p.M251V variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.M251V missense variant is predicted to be damaging by both SIFT and PolyPhen2. The methionine residue at codon 251 of SCN1A is conserved in all mammalian species. The nucleotide c.751 in SCN1A is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. | |
Department of Neurology, |
RCV005242105 | SCV005889660 | likely pathogenic | Generalized epilepsy with febrile seizures plus, type 2; Developmental and epileptic encephalopathy 6B | 2025-01-09 | criteria provided, single submitter | clinical testing | PM1, PM2_Supporting, PM5, PP2, PP3_Moderate |